COVID-19 vaccines in patients with urothelial cancers receiving immune checkpoint inhibitors.

被引：0
|
作者：
Gilbert, Danielle
Hu, Junxiao
Lam, Elaine T.
机构：
[1] Univ Colorado, Sch Med, Aurora, CO USA
[2] Univ Colorado, Ctr Canc, Aurora, CO USA
[3] Univ Colorado, Ctr Comprehens Canc, Aurora, CO USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
491
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Genetic determinants of adverse events in cancer patients receiving immune checkpoint inhibitors.
    Abdel-Wahab, Noha
    Yu, Robert K.
    Diab, Adi
    Dadu, Ramona
    Shannon, Vickie
    Futreal, Andrew
    Criswell, Lindsey A.
    Shete, Sanjay
    Suarez-Almazor, Maria E.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [22] COVID-19 vaccination in patients with cancer receiving immune checkpoint inhibitors: a systematic review and meta-analysis
    Ruiz, Juan Ignacio
    Lopez-Olivo, Maria Angeles
    Geng, Yimin
    Suarez-Almazor, Maria E.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (02)
  • [23] Clinical and immunologic implications of COVID-19 in patients with melanoma and renal cell carcinoma receiving immune checkpoint inhibitors
    Switzer, Benjamin
    Haanen, John
    Lorigan, Paul C.
    Puzanov, Igor
    Turajlic, Samra
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (07)
  • [24] Incidence and economic burden of infections in cancer patients receiving immune checkpoint inhibitors.
    Nalluru, Swarna Sri
    Piranavan, Paramarajan
    Narimiti, Anvesh
    Shah, Shanil
    Siddiqui, Ahmad Daniyal
    Abraham, George
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [25] COVID-19 and immune checkpoint inhibitors: initial considerations
    Sullivan, Ryan J.
    Johnson, Douglas B.
    Rini, Brian, I
    Neilan, Tomas G.
    Lovly, Christine M.
    Moslehi, Javid J.
    Reynolds, Kerry L.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [26] On the use of immune checkpoint inhibitors in patients with viral infections including COVID-19
    Gambichler, Thilo
    Reuther, Judith
    Scheel, Christina H.
    Becker, Juergen Christian
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [27] COVID-19 in 3 patients treated with immune checkpoint inhibitors for advanced melanoma
    Arenbergerova, M.
    Gkalpakiotis, S.
    Arenberger, P.
    Fialova, A.
    Pasek, M.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (03) : 1782 - 1783
  • [28] Impact of body mass index on survival rates in patients receiving immune checkpoint inhibitors.
    Maslov, Diana
    Tawagi, Karine
    Simenson, Victoria
    Yuan, Helen
    Parent, Cameron
    Bamnolker, Adi
    Goel, Richa
    Blake, Zoe
    Madhav, K. C.
    Matrana, Marc Ryan
    Johnson, Daniel H.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [29] Immune Checkpoint Inhibitors for Cancer Therapy in the COVID-19 Era
    Maio, Michele
    Hamid, Omid
    Larkin, James
    Covre, Alessia
    Altomonte, Maresa
    Calabro, Luana
    Vardhana, Santosh A.
    Robert, Caroline
    Ibrahim, Ramy
    Anichini, Andrea
    Wolchok, Jedd D.
    Di Giacomo, Anna Maria
    CLINICAL CANCER RESEARCH, 2020, 26 (16) : 4201 - 4205
  • [30] Immune-related adverse events (irAE) in GU cancer patients receiving immune checkpoint inhibitors.
    Zang, Peter
    Drakaki, Alexandra
    Faiena, Izak
    Chan, Betty
    Tsao-Wei, Denice
    Groshen, Susan G.
    Quinn, David I.
    Dorff, Tanya B.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
12345